- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
回复 newchinabok 的帖子
May 6, 2015
Previous Release | Next Release
PDF Add to Briefcase
TetraLogic Announces Temporary Halt of Chronic Hepatitis B Trial
MALVERN, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced that it has temporarily halted enrollment in the birinapant chronic hepatitis B multiple ascending dose trial, currently being conducted in Australia, due to cranial nerve palsies observed in the first cohort.
2015年5月6日
先前版本|下一页发布
PDF添加到公文包
TetraLogic宣布慢性乙型肝炎审判暂时停止
宾夕法尼亚,MALVERN,2015年5月6日(GLOBE NEWSWIRE) - TetraLogic制药公司(纳斯达克股票代码:TLOG),临床阶段的生物制药公司,专注于肿瘤学和传染病发现和开发创新的小分子疗法,今天宣布,它已暂时停止登记在birinapant慢性乙型肝炎多剂量递增试验中,目前在澳大利亚进行的,由于在第一组观察颅神经麻痹。 |
|